Cancer cures are finally here?
A clinical trial has recently discovered that each and every rectal cancer patient who was subjected to the experimental treatment witnessed their disease vanish. This appears to be a miracle and it happened for the first time in history. Dostarlimab is the medicine that was taken by 18 patients for six months in a limited clinical trial which was performed by the Memorial Sloan Kettering Cancer Center for cancer treatment and all the patients saw that their tumors had shrunk in the end.
The experts have also stated that the malignancy has been undetectable through physical examination, endoscopy, positron emission tomography or PET scans, and MRI scans. It means that Dostarlimab has all the potential to be a possible cure for Cancer and for one of the most deadly tumors.
This is “the first time this has happened in the history of cancer,” according to Dr. Luis A. Diaz J. of Memorial Sloan Kettering Cancer Center in New York. According to the specialists, Dostarlimab is a medicine that is made in a lab and functions as a surrogate for the antibodies in the human body.
Patients previously in the clinical experiments received treatments like chemotherapy, radiation as well as invasive surgery. All these could have potentially caused bowel, urinary and sexual dysfunction. As per the next step in the research the 18 patients expected that they have to go through these surgeries. But, they were surprised when they learned that there was no more therapy that was required.
On the other hand, even the experts were left astounded by the outcome of the trial and stated that the total remission in every patient is never heard of. Dr. Alan P. Venook, the colorectal cancer specialist at the University Of California, said that complete remission in every single patient is “unheard-of”. He acclaimed the research as “world-first”.
Experts have praised the study as there were not any serious side effects on most people who participated in the trial medication. Oncologist, Dr. Andrea Cerceck said, “There were a lot of happy tears”. When they learned that they were cancer-free.
According to the doctors, the patients took Dostarlimab every three weeks consecutively for six months. “It is noteworthy that they were all in similar stages of their cancer. The cancer was locally advanced in the rectum but had not spread to other organs,” said the doctors.
“At the time of the report, no patients had received chemoradiotherapy or undergone surgery, and no cases of progression or recurrence had been reported during follow-up,” researchers wrote in the study published in the media outlet.
The cancer researchers who studied the medicine said that it appears to be very promising though a larger-scale trial is what’s required.
